Physician profile
Timothy W Weaver
NPI 1831410752
$2,439.94
in general payments reported to CMS, 2019-2025
11 companies · $2,169 in 2025
The $2,169 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.25 · 2022: $58.81 · 2023: $136 · 2024: $29.97 · 2025: $2,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,121 · Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,120.62 |
| Food and Beverage | $214.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,120.62 | 2025 | |
| Davol INC. | $155.77 | 2021-2025 | Phasix Mesh |
| Otsuka America Pharmaceutical, INC. | $29.64 | 2023 | Abilify Maintena, Rexulti |
| Allergan, INC. | $29.32 | 2021-2022 | |
| Kci USA, INC. | $19.39 | 2023 | Activ.A.C., Prevena |
| Glaxosmithkline, LLC. | $15.49 | 2024 | Trelegy Ellipta |
| Hologic Sales and Service, LLC | $15.08 | 2025 | Aptima, Thinprep 2000 Processor |
| Novo Nordisk INC | $14.48 | 2024 | Rybelsus, Ozempic |
| Integra Lifesciences Corporation | $14.16 | 2021 | |
| Medtronic, INC. | $13.61 | 2023 | Ligasure |
| Merck Sharp & Dohme LLC | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.